Goldman Sachs Reports 5.2% Passive Stake in Indivior PLC (INVVY)
INDIVIOR PLC
Subscribe to track INDV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Goldman Sachs Reports 5.2% Passive Stake in Indivior PLC (INVVY)
Company: INDIVIOR PLC (INVVY) Form: SCHEDULE 13G/A | Filed: 2025-11-12 Significance: Medium
Reporting Entity: THE GOLDMAN SACHS GROUP, INC. Relationship: Institutional Investor / >5% Owner
Holding Details: • Type: Statement of Passive Ownership • Security: Ordinary Shares • Shares Held: 6,531,869 • Stake: 5.2% of class
Key Insight: This filing amends Goldman Sachs' previously disclosed passive investment in the pharmaceutical company Indivior PLC, reaffirming their position as a significant institutional shareholder with a 5.2% stake.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: INDIVIOR PLC
Executive Summary
- Trading Significance: Medium
- Key Takeaway: Goldman Sachs Group filed a Schedule 13G/A, amending its reported passive ownership stake in Indivior PLC to 6,531,869 shares, representing 5.2% of the company's ordinary shares.
- Market Impact: This filing reaffirms a significant, passive institutional position, which is generally a neutral to slightly positive signal of stability for the subject company, Indivior PLC.
Filing Information
| Field | Value |
|---|---|
| Subject Company | INDIVIOR PLC |
| Subject CIK | 0001625297 |
| Ticker Symbol | INVVY (ADR) |
| Filer | THE GOLDMAN SACHS GROUP, INC. |
| Filer CIK | 0000886982 |
| Form Type | SCHEDULE 13G/A |
| Event Date | 2025-09-30 |
Ownership Details
| Field | Value |
|---|---|
| Security Type | Ordinary shares, $0.50 nominal value per share |
| Shares Beneficially Owned | 6,531,868.75 |
| Percent of Class | 5.2% |
| Shared Voting Power | 6,531,833.75 |
| Shared Dispositive Power | 6,531,868.75 |
| Nature of Ownership | Passive Investment (Not for control) |
Financial Impact Assessment
Transaction Materiality
Note: The provided market data pertains to the filer (Goldman Sachs), not the subject company (Indivior PLC). Therefore, a quantitative analysis of the holding's value as a percentage of Indivior PLC's market capitalization cannot be performed.
Impact Evaluation
- Ownership Concentration: Goldman Sachs holds a 5.2% stake, making it a significant institutional owner. Such a position can provide a degree of share price stability. As a passive stake (Rule 13d-1(b)), it indicates the investment is not intended to influence the control of Indivior PLC.
- Institutional Conviction: This amended filing reaffirms Goldman Sachs' position in the specialty pharmaceutical company. While it's an amendment and not a new position, maintaining a stake above the 5% reporting threshold is a notable data point for investors tracking institutional money flow.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is an amendment to an existing passive holding, not a new purchase or activist campaign. It confirms the status quo of Goldman Sachs being a major shareholder, which is already known to the market. The filing itself is unlikely to cause significant price movement.
Volume & Sentiment
- Expected Volume Impact: Low. Schedule 13G/A filings, especially from large institutions, are routine disclosures and rarely drive short-term trading volume.
- Sentiment Indicator: Neutral. The filing confirms a large institution's continued passive investment, which can be viewed as a sign of stability, but it does not signal any new bullish or bearish catalyst.
Investment Insights
Key Takeaways
- Significant Institutional Stake: Goldman Sachs remains a major shareholder in Indivior PLC with a 5.2% passive stake.
- Passive Investment: The filing under Rule 13d-1(b) certifies that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
- Amendment Filing: This is an update (Amendment No. 2) to a previously reported position, not the initiation of a new stake, making it a routine disclosure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
